Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 7, 2001, Pages 2160-2162

  Villani, P ^a   Viale, P ^a   Signorini, L ^a   Cadeo, B ^a   Marchetti, F ^a   Villani, A ^a   Fiocchi, C ^a   Regazzi, M B ^a   Carosi, G ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; LEVOFLOXACIN; NELFINAVIR; ZIDOVUDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PNEUMONIA; PRIORITY JOURNAL; STEADY STATE;

ADMINISTRATION, ORAL; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; COHORT STUDIES; DRUG INTERACTIONS; HIV INFECTIONS; HUMANS; NELFINAVIR; OFLOXACIN; OXAZINES; PROSPECTIVE STUDIES;

EID: 0034963037     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.7.2160-2162.2001     Document Type: Article

References (15)

1. Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys
2. Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects
3. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudin
4. Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid
5. The clinical pharmacokinetics of levofloxacin
6. Pharmacokinetics and safety of levofloxacin in patients with human immunodeficieney virus infection
7. Bacterial pneumonia in person infected with the HIV
8. Drug-drug interactions with fluoroquinolones
9. Interactions of fluoroquinolones with other drugs: Mechanisms, variability, clinical significance and management
10. Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during the rescue treatment of heavily pretreated HIV-infected patients
11. A reverse-phase isocratic high-performance liquid chromatography assay for levofloxacin
12. Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid
13. High-performance liquid chromatographic method for analysing the antiretroviral agent efavirenz in human plasma
14. Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients
15. High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma